Hand-foot-genital syndrome

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Hand-foot-genital syndrome | |
|---|---|
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Limb malformation, urinary tract abnormalities, genital abnormalities |
| Complications | Urinary tract infections, infertility |
| Onset | Congenital |
| Duration | Lifelong |
| Types | N/A |
| Causes | Mutations in the HOXA13 gene |
| Risks | Family history |
| Diagnosis | Clinical diagnosis, genetic testing |
| Differential diagnosis | Urofacial syndrome, VACTERL association |
| Prevention | N/A |
| Treatment | Surgical intervention, supportive care |
| Medication | N/A |
| Prognosis | Variable, depending on severity |
| Frequency | Rare |
| Deaths | N/A |
A rare genetic disorder affecting limb and urogenital development
Hand-foot-genital syndrome (HFGS) is a rare autosomal dominant genetic disorder characterized by limb malformations and urogenital anomalies. It is caused by mutations in the HOXA13 gene, which plays a crucial role in the development of the limbs and the urogenital tract.
Clinical Features[edit]
Individuals with hand-foot-genital syndrome typically present with a combination of limb and urogenital abnormalities. The severity and specific manifestations can vary among affected individuals.
Limb Abnormalities[edit]
- Hand Malformations: Patients often exhibit brachydactyly, which is the shortening of the fingers and toes. The thumbs may be particularly affected, showing hypoplasia or underdevelopment. - Foot Malformations: Similar to the hands, the feet may also show brachydactyly. There may be additional anomalies such as clubfoot or other positional deformities.
Urogenital Anomalies[edit]
- Females: Affected females may have uterine didelphys, a condition where the uterus is duplicated, or other Müllerian duct anomalies. - Males: Affected males may present with hypospadias, where the opening of the urethra is on the underside of the penis rather than at the tip.
Genetics[edit]
Hand-foot-genital syndrome is caused by mutations in the HOXA13 gene, which is located on chromosome 7p15.2. This gene is part of the homeobox gene family, which is involved in regulating patterns of anatomical development (morphogenesis) in animals, fungi, and plants. The condition is inherited in an autosomal dominant manner, meaning that a single copy of the altered gene in each cell is sufficient to cause the disorder. This also implies that an affected individual has a 50% chance of passing the mutation to their offspring.
Diagnosis[edit]
Diagnosis of hand-foot-genital syndrome is primarily based on clinical evaluation and the identification of characteristic physical features. Genetic testing can confirm the diagnosis by identifying mutations in the HOXA13 gene.
Management[edit]
Management of hand-foot-genital syndrome is symptomatic and supportive. It may involve: - Orthopedic Interventions: Surgical correction of limb deformities may be necessary to improve function and mobility. - Urological and Gynecological Care: Management of urogenital anomalies may require surgical intervention and ongoing medical care. - Genetic Counseling: Families may benefit from genetic counseling to understand the inheritance pattern and implications for family planning.
Prognosis[edit]
The prognosis for individuals with hand-foot-genital syndrome varies depending on the severity of the symptoms and the presence of any associated complications. With appropriate management, many individuals can lead relatively normal lives.
See also[edit]
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99


W8MD Medical Weight Loss, Sleep and Medspa offers physician-supervised medical weight loss programs: NYC medical weight loss Philadelphia medical weight loss
Affordable GLP-1 Weight Loss ShotsAffordable GLP-1 Weight Loss Shots
Budget GLP-1 injections NYC (insurance & self-pay options) Popular treatments:
- Semaglutide starting from $29.99/week
- Tirzepatide starting from $45.00/week
✔ Most insurances accepted for visits ✔ Prior authorization support when eligible
Start your physician weight loss NYC journey today:
📍 NYC: Brooklyn weight loss center 📍 Philadelphia: Philadelphia weight loss center
📞 Call: 718-946-5500 (NYC) | 215-676-2334 (Philadelphia)
Tags: Affordable GLP1 weight loss NYC, Wegovy NYC, Zepbound NYC, Philadelphia medical weight loss
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian